Evidence map›Paper›PMID 29808091›Full record

ArticleInternational journal of endocrinology2018

Risk of Microvascular Complications and Macrovascular Risk Factors in Early-Onset Type 1 Diabetes after at Least 10 Years Duration: An Analysis of Three Population-Based Cross-Sectional Surveys in Germany between 2009 and 2016.

Thaddäus Tönnies, Anna Stahl-Pehe, Christina Baechle, Katty Castillo, Oliver Kuss, Rhuphine Yossa, Lena M E Lindner, Reinhard W Holl, Joachim Rosenbauer

Open access · goldAbstract read
In one paragraph

Article in International journal of endocrinology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 28 citations in OpenAlex.

  1. The Association Between HbADiabetes care · 2020
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Thaddäus TönniesInstitute for Biometrics and Epidemiology, German Diabetes Centre (DDZ), Leibniz Centre for Diabetes Research, Heinrich Heine University, Auf'm Hennekamp 65, 40225 Duesseldorf, Germany.ORCID 0000-0003-1577-4212
Anna Stahl-PeheInstitute for Biometrics and Epidemiology, German Diabetes Centre (DDZ), Leibniz Centre for Diabetes Research, Heinrich Heine University, Auf'm Hennekamp 65, 40225 Duesseldorf, Germany.ORCID 0000-0002-5281-6023
Christina BaechleInstitute for Biometrics and Epidemiology, German Diabetes Centre (DDZ), Leibniz Centre for Diabetes Research, Heinrich Heine University, Auf'm Hennekamp 65, 40225 Duesseldorf, Germany.ORCID 0000-0003-1262-7591
Katty CastilloInstitute for Biometrics and Epidemiology, German Diabetes Centre (DDZ), Leibniz Centre for Diabetes Research, Heinrich Heine University, Auf'm Hennekamp 65, 40225 Duesseldorf, Germany.
Oliver KussInstitute for Biometrics and Epidemiology, German Diabetes Centre (DDZ), Leibniz Centre for Diabetes Research, Heinrich Heine University, Auf'm Hennekamp 65, 40225 Duesseldorf, Germany.
Rhuphine YossaInstitute for Biometrics and Epidemiology, German Diabetes Centre (DDZ), Leibniz Centre for Diabetes Research, Heinrich Heine University, Auf'm Hennekamp 65, 40225 Duesseldorf, Germany.
Lena M E LindnerInstitute for Biometrics and Epidemiology, German Diabetes Centre (DDZ), Leibniz Centre for Diabetes Research, Heinrich Heine University, Auf'm Hennekamp 65, 40225 Duesseldorf, Germany.
Reinhard W HollGerman Centre for Diabetes Research (DZD), Ingolstädter Landstraße 1, 85764 Neuherberg, Germany.
Joachim RosenbauerInstitute for Biometrics and Epidemiology, German Diabetes Centre (DDZ), Leibniz Centre for Diabetes Research, Heinrich Heine University, Auf'm Hennekamp 65, 40225 Duesseldorf, Germany.ORCID 0000-0002-6086-2230
Deutsches Diabetes-Zentrum e.V. · DEUniversität Ulm · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTo estimate the risk of microvascular complications and macrovascular risk factors among persons with early-onset (diagnosed at ages 0 to <5 years) and long-duration type 1 diabetes and determine temporal trends and associations with potential predictors.

methodsWe conducted three population-based cross-sectional surveys in Germany (

resultsThe risk for microvascular complications increased after 14 years since diabetes diagnosis whereas dyslipidemia and hypertension were already prevalent at 10 years. The 15-year risk (95% confidence interval) of the composite endpoint for female and male patients was 22.9% (18.8%-27.9%) and 19.2% (15.5%-23.8%), respectively. Temporal trends suggested a decreasing risk between 2009 and 2016. Glycemic control, lifestyle-related factors, and SES, but not health care-related factors, were associated with the risk of the composite endpoint.

conclusionsIn early-onset type 1 diabetes, there exists a considerable risk of complications and comorbidities already in young ages. Future research should focus on prevention of diabetic complications in young patients and clarification of pathways of the associations found.

Identifiers

PMID29808091
PMCPMC5901480
OpenAlexW2795350260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.